检索结果 - Annette Reichardt

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors

    Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors 由 Sebastian Bauer, R A Hilger, Thomas Mühlenberg, Florian Grabellus, James Nagarajah, Mathias Hoiczyk, Annette Reichardt, Marit Ahrens, Peter Reichardt, Susanne Grünewald, M. E. Scheulen, A. Pustowka, E Bock, Martin Schüler, Daniel Pink

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial

    Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial 由 Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H. Lindner, Philipp J. Jost, Sebastian Bauer, J. Schütte, S. Lindskog, Raija Kallio, Panu Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

    <i>KIT</i> and <i>PDGFRA</i> Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial 由 Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, Jochen Schütte, Silke Cameron, Peter Hohenberger, Harri Sihto, Philipp J. Jost, Lars H. Lindner, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Tommi Pesonen, Peter Reichardt

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Effect of <i>KIT</i> and <i>PDGFRA</i> Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib

    Effect of <i>KIT</i> and <i>PDGFRA</i> Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib 由 Heikki Joensuu, Eva Wardelmann, Harri Sihto, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Jörg T. Hartmann, Daniel Pink, Silke Cameron, Peter Hohenberger, Salah‐Eddin Al‐Batran, M. Schlemmer, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Jouni Junnila, Aki Vehtari, Peter Reichardt

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors

    Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors 由 Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Annette Reichardt, Bárbara Hermes, J. Schütte, Silke Cameron, Peter Hohenberger, Philipp J. Jost, Salah‐Eddin Al‐Batran, Lars H. Lindner, Sebastian Bauer, Eva Wardelmann, Bengt Nilsson, Raija Kallio, Panu Jaakkola, Jouni Junnila, Thor Alvegård, Peter Reichardt

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors

    A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors 由 George D. Demetri, Paolo G. Casali, Jean‐Yves Blay, Margaret von Mehren, Jeffrey A. Morgan, Rossella Bertulli, Isabelle Ray‐Coquard, Philippe A. Cassier, Monica Davey, Hossein Borghaei, Daniel Pink, Maria Dębiec‐Rychter, Wing K. Cheung, Stuart M. Bailey, Maria Luisa Veronese, Annette Reichardt, Elena Fumagalli, Peter Reichardt

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: